Alexander Douglas
0000-0002-5410-7562
Oxford University
3 papers found
Refreshing results…
Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial
Simian adenovirus vector production for early-phase clinical trials: A simple method applicable to multiple serotypes and using entirely disposable product-contact components
A defined mechanistic correlate of protection against Plasmodium falciparum malaria in non-human primates
Missing publications? Search for publications with a matching author name.